AutoGen, Inc., a leading provider of nucleic acid extraction equipment, announces that they have signed an agreement with STRATEC Molecular GmbH of Berlin, Germany, a wholly owned subsidiary of STRATEC Biomedical AG, to distribute the InviGenius Plus throughout North America.
The InviGenius is a fully-automated benchtop system for medium throughput extraction of DNA and RNA. Chief among its applications are, cfDNA from large volumes of plasma, genomic DNA from large volumes of whole blood and saliva, DNA from FFPE samples, pathogen DNA and RNA from clinical relevant samples and RNA from whole blood.
“We are happy to offer the InviGenius Plus to our customer base”, said Bob Sullivan CEO of AutoGen, Inc. “It provides extraction applications that our customers and potential customers have been seeking for some time. STRATEC provides innovative products with high reliability and robust design. The InviGenius will be a terrific addition to our product line. As always, customers can expect the highest levels of service and support from AutoGen’s technical team.”
About AutoGen, Inc.
Headquartered in Holliston, MA, within easy reach of Boston’s biotech and research centers, AutoGen is a privately held, value-added supplier of nucleic acid extraction equipment and sample preparation solutions to the life science community. AutoGen is a recognized leader in providing automated nucleic acid extraction systems to the biobanking and molecular research communities, serving customers in biorepositories, contract research organizations, academic research laboratories, pharmaceutical and clinical diagnostic companies, and government institutions. The company’s mission is to provide products of superior quality and value, backed by scientific and technical support that exceeds the requirements of its clients.
AutoGen has a rich history of development experience and technical knowledge in automated nucleic acid extraction systems. This heritage gives the AutoGen team the know-how and skills to support all aspects of its equipment and systems. As a result, clients throughout the United States receive the highest caliber training, maintenance, application and mechanical support. A network of specialized distributors supports AutoGen’s clients in Europe, Canada, Mexico, Middle East, and South America.
STRATEC Biomedical AG (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers sample preparation solutions, integrated laboratory software, and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain – from development to design and production through to quality assurance.
The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies.
Through its subsidiary STRATEC Molecular GmbH, the STRATEC Group also provides products for manual and automated DNA and RNA extraction from a broad variety of samples starting with sample collection, stabilization and purification.
Founded as an independent development and research facility in 1992, STRATEC Molecular has become internationally renowned for its expertise in developing and commercializing products for manual and automated applications in clinical diagnostics and life science research.
Together with instrumentation, software and consumables, STRATEC offers an entire range of fully automated system solutions for tomorrow’s challenges in NAT sample preparation.